Skip to content
Rounds
0:00 / 0:00

Alzheimer’s Disease — Anti-Amyloid Medications, Early Detection, and Screening | NEJM

NEJM Group

214K subscribers • 36 videos on Rounds • Health institution

YouTube
  • Published by NEJM Group, one of the health institutions Rounds lists. Nobody has recommended it in the communities yet, so it ranks below community picks.
  • Presented by Drs. Nathaniel Chin and Stephen Salloway, as the video describes them
  • The description links 1 paper.
  • Debated among experts. Its central claim is contested, so look for the other side.

Aimed at clinicians, students or researchers. Education, not medical advice.

71K views2 years ago

Brain and nervesMedicines and supplementsDementia and Alzheimer'sHow drugs workDiagnosis and clinical reasoning

Drs. Nathaniel Chin and Stephen Salloway review the pathophysiology of Alzheimer's and the clinical use of anti-amyloid medications.

In this Double Take video from the New England Journal of Medicine, Drs. Nathaniel Chin and Stephen Salloway review the pathophysiology of Alzheimer’s disease and discuss how anti-amyloid medications can help in early stages of the disease. The video notes disparities in diagnosis and treatment of Alzheimer’s disease and provides guidance on screening and diagnosis and on which patients should be referred to specialty care. A related podcast, referenced in the video, is available at nejm.org/doi/full/10.1056/NEJMp2309485 : Intention to Treat, episode 20: Alzheimer's Update, Part 1 (November 9, 2023). The New England Journal of Medicine is the world’s leading general medical journal. Continuously published for over 200 years, the Journal publishes peer-reviewed research along with interactive clinical content for physicians, educators, and the global medical community at NEJM.org. #medicaleducation #alzheimersawareness #alzheimersdisease #nejm

Why it's here

From a health institution

NEJM Group is on Rounds' list of health institutions, and this upload is one of its most-watched lectures or explainers. Nobody has recommended it in the communities yet, so it ranks below community picks.